Salute e Benessere | Diffusione Gratuita di Comunicati Stampa in inglese| Pubblica i tuoi comunicati con informazione.news

Bavarian Nordic Submits Marketing Authorization Application for its Chikungunya…

Regulatory review of the single-dose CHIKV VLP vaccine candidate for immunization to prevent disease caused by chikungunya virus infection in individuals 12 years of age and older is now underway in both the EU and in the U.S.COPENHAGEN, Denmark, June 26, 2024– Bavarian Nordic A/S (OMX: BAVA) today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) seeking approval of the Company's vaccine candidate for immunization to prevent...

Saw Palmetto Berries Market to Reach $325.6 Million, Globally, by 2035 at 5.6%…

Download PDF Brochure: https://www.alliedmarketresearch.com/request-sample/A32241 Download PDF Brochure: https://www.alliedmarketresearch.com/request-sample/A32241 Prime determinants of growth One of the major drivers in the saw palmetto berries market is primarily driven by increasing awareness about the health benefits of saw palmetto berries, particularly in promoting prostate health and managing urinary symptoms, fuels demand. Moreover, rising consumer preference for natural...

Crossject elaborates on ZEPIZURE® potential in light of landmark RAMPART study…

Landmark RAMPART study established midazolam intramuscular (IM) injection as a standard of care in the pre-hospital emergency management of epilepsy crises compared to traditional benzodiazepine intravenous (IV)Crossject's bioequivalence study, recently published inNeurology and Therapy, remarkably consistent with RAMPART's findings and authors' viewsDijon, France 26 June, 2024 -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company in advanced phases of...

ONWARD® Medical Announces Participation in Stifel European Healthcare Summit

CEO Dave Marver will meet with investors to discuss the Company's achievements and upcoming milestones th. CEO Dave Marver will meet with current and potential ONWARD Medical investors from leading European specialist and generalist funds.To learn more about ONWARD Medical's commitment to partnering with the SCI Community to develop innovative solutions for restoring movement, function, and independence after spinal cord injury, please visitONWD.com. *All ONWARD ®Medical...

dsm-firmenich issues €800 million long-term bond

The terms are laid down in the €8 billion Debt Issuance Program of dsm-firmenich alongside the Final Terms of this issuance, both of which are available here. The terms are laid down in the €8 billion Debt Issuance Program of dsm-firmenich alongside the Final Terms of this issuance, both of which are availablehere. The re-offer price for the ten-year bond tranche was 99.456%. Based on this price, the yield is 3.691%. The bonds will shortly be listed on the Luxembourg Stock Exchange...

Apollo Cancer Centres Collaborates With Accuray to Launch India Sub- Continent's…

Dr Sridhar PS, Lead- Cyberknife – Robotic Radiosurgery, said, "The launch of the training program at Apollo Cancer Centre is an exceptional opportunity to enhance skills and knowledge in Robotic & Stereotactic Radiotherapy . Since pioneering the Cyberknife Robotic Radio Surgery System in India and a rich experience of over 5000 patients, we will now share the valuable knowledge in the training program. It will enable oncologists in the development of Cancer care through Cyberknife…

Zealand Pharma announces completion of an upsized equity offering of 8.35…

Company announcement – No. 35 / 2024Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary shares raising gross proceeds of USD 1 billion / DKK 7 billion NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA, EXCEPT AS PERMITTED BY APPLICABLE LAW. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY SECURITIES IN THE UNITED...

Corneal Ulcer Market to Increase at a Steady Growth Rate During the Study Period…

Key Takeaways from the Corneal Ulcer Market Report Key Takeaways from the Corneal Ulcer Market Report Discover which therapies are expected to grab the major corneal ulcer market share @Corneal Ulcer Market Report Corneal Ulcer Overview A corneal ulcer is a serious condition characterized by an open sore on the cornea, the clear, dome-shaped surface that covers the front of the eye. This ulcer can result from various causes, including bacterial, viral, fungal, or parasitic...

Skyhawk Therapeutics Expands into State-of-the-Art Labs in its Basel…

"This is an exciting time at Skyhawk," said Clint Musil, Chief Executive Officer of Skyhawk Therapeutics. "With our first program for Huntington's disease progressing in the clinic and our second program, SKY-1214, on track to enter the clinic, we've doubled our lab space in Basel to drive a series of promising INDs. Superlab Suisse is a leading provider of innovative research space and the largest private lab space in Switzerland, with a mission to provide dynamic infrastructure…

Zealand Pharma announces upsizing of previously announced equity offering from…

Company announcement – No. 34 / 2024 Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billionNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA, EXCEPT AS PERMITTED BY APPLICABLE LAW. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY SECURITIES IN THE...

Press Release: Availability of the Q2 2024 Aide-mémoire

Availability of the Q2 2024 Aide-mémoireParis, France – June 25, 2024. Sanofi announced that its Q2 2024 Aide-mémoire is available on the "Investors" page of the company's website: https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/q2-results-2024 As for each quarter, Sanofi prepared this document to assist in the financial modelling of the Group's quarterly results. This document includes a reminder on various non-comparable items and exclusivity...

IPSEN - Buy-back programme - Art 5 of MAR - Week 25 - 2024

AggregatedpresentationbydayandbymarketPurchases of own shares from June 17th to 21th 2024 Name of the IssuerIdentity code of the IssuerDay of the transactionIdentity code of the financial instrumentTotal daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code) IPSEN549300M6SGDPB4Z94P1117/06/2024FR00102591506 600120,3723XPARIPSEN549300M6SGDPB4Z94P11...

Higher cantonal composition authority approved the amendments to the terms of…

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – June 25, 2024Idorsia Ltd (SIX: IDIA) today announced that the hearing by the higher cantonal composition authority ( obere kantonale Nachlassbehörde ) (the Court) in relation to its outstanding convertible bonds originally maturing on July 17, 2024 (ISIN: CH0426820350) (the Bonds), was held today and that the Court approved the amendments of the Bond terms decided at the bondholder meeting held on May 6, 2024.Idorsia...

New publication shows effectiveness data for weekly and monthly buprenorphine…

Of 428 trial participants, 123 (SC-BPN, n=64; SL-BPN/NX, n=59) had evidence of baseline fentanyl use. In the fentanyl-positive subgroup, the mean percentage of urine samples negative for fentanyl during the study was 74% for the SC-BPN arm versus 61.9% for the SL BPN/NX arm). Withdrawal symptoms and cravings decreased following treatment initiation in patients positive for fentanyl use at baseline. No substantial difference was observed in rates of study completion between fentanyl-positive and…

Neurolief Announces Breakthrough Results from Pivotal Clinical Trial of Brain…

The double-blind, randomized, placebo-controlled, multi-center clinical trial enrolled 124 participants across leading medical centers in the United States and Israel. The study's primary endpoint was a reduction in depression severity as measured by the Hamilton Depression Rating Scale (HDRS17). Key findings from the trial include: The double-blind, randomized, placebo-controlled, multi-center clinical trial enrolled 124 participants across leading medical centers inthe United…

Zealand Pharma launches equity offering of new shares raising gross proceeds of…

Company announcement – No. 33 / 2024Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 900 million / DKK 6.257 billionNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA, EXCEPT AS PERMITTED BY APPLICABLE LAW. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY SECURITIES IN THE UNITED STATES AND THE SECURITIES...

Defibrillator Market to be Worth $22.76 Billion by 2031 - Exclusive Report by…

Cardioverter defibrillators are devices that detect and control heartbeats, also known as arrhythmia, and deliver electric shocks to restore a regular heart rhythm. Cardioverter defibrillators are devices that detect and control heartbeats, also known as arrhythmia, and deliver electric shocks to restore a regular heart rhythm. The growth of the defibrillator market is driven by several factors, including the increasing burden of cardiovascular diseases and the rise in obesity, sedentary...

Research Antibodies and Reagents Market to be Worth $6.77 Billion by 2031 -…

Research antibodies are crucial for research in several fields, including oncology, infectious diseases, cardiology, immunology, neurology, and stem cell research. Antibodies help in protein identification and detection, which can be associated with specific diseases. Furthermore, antibodies are also used in the identification of novel biomarkers which help in disease diagnosis. Research antibodies are crucial for research in several fields, including oncology, infectious diseases…

SyMRI 15 by SyntheticMR obtains CE-Marking

Evaxion Receives Positive Feedback on Patent Application for AI-Based Novel…

Tiziana Life Sciences to Dose First Patient with Moderate Alzheimer's Disease…

Compass Pathways appoints Lori Englebert as Chief Commercial Officer

ADOLFO DOMÍNGUEZ PRESENTS HIS NEW FASHION AND FRAGRANCE COLLECTION AT A WORLD…

Alvotech Receives Conversion Notices for Majority of Convertible Bonds

Bavarian Nordic Submits Marketing Authorization Application for its Chikungunya…

Saw Palmetto Berries Market to Reach $325.6 Million, Globally, by 2035 at 5.6%…

Crossject elaborates on ZEPIZURE® potential in light of landmark RAMPART study…

ONWARD® Medical Announces Participation in Stifel European Healthcare Summit

dsm-firmenich issues €800 million long-term bond

Apollo Cancer Centres Collaborates With Accuray to Launch India Sub- Continent's…

Zealand Pharma announces completion of an upsized equity offering of 8.35…

Corneal Ulcer Market to Increase at a Steady Growth Rate During the Study Period…

Skyhawk Therapeutics Expands into State-of-the-Art Labs in its Basel…

Zealand Pharma announces upsizing of previously announced equity offering from…

Press Release: Availability of the Q2 2024 Aide-mémoire

IPSEN - Buy-back programme - Art 5 of MAR - Week 25 - 2024

Higher cantonal composition authority approved the amendments to the terms of…

New publication shows effectiveness data for weekly and monthly buprenorphine…

Neurolief Announces Breakthrough Results from Pivotal Clinical Trial of Brain…

Zealand Pharma launches equity offering of new shares raising gross proceeds of…

Defibrillator Market to be Worth $22.76 Billion by 2031 - Exclusive Report by…

Research Antibodies and Reagents Market to be Worth $6.77 Billion by 2031 -…